Skip to search.
 TSX Up 0.71% TSX Ventures Up 1.85%

XOMA Corporation (XOMA)

-NasdaqGM
0.86 Up 0.04(4.70%) Aug 28, 3:59PM EDT
|After Hours : 0.86 Down 0.00 (0.01%) Aug 28, 4:29PM EDT
Add to Portfolio
Prev Close:0.83
Open:0.82
Bid:0.74 x 9000
Ask:0.87 x 500
1y Target Est:4.17
Beta:3.06558
Earnings Date:Nov 4 - Nov 9 (Est.)
Day's Range:0.80 - 0.87
52wk Range:0.69 - 5.95
Volume:2,210,492
Avg Vol (3m):5,850,200
Market Cap:102.44M
P/E (ttm):N/A
EPS (ttm):-0.71
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
XOMAUp 4.70%102.44M
REGNDown 0.24%56.71B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):6.67
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.64
Quarterly EPS Est (Sep-15) :-0.16
Mean Recommendation*:2.7
PEG Ratio (5 yr expected):-0.07

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

XOMA Corporation discovers and develops antibody-based therapeutics in the United States, Europe, and the Asia Pacific. The company’s lead product candidate includes gevokizumab, a proprietary humanized allosteric-modulating monoclonal antibo... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback